BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Belsky JA, Tullius BP, Lamb MG, Sayegh R, Stanek JR, Auletta JJ. COVID-19 in immunocompromised patients: A systematic review of cancer, hematopoietic cell and solid organ transplant patients. J Infect 2021;82:329-38. [PMID: 33549624 DOI: 10.1016/j.jinf.2021.01.022] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Dęborska-Materkowska D, Kamińska D. The Immunology of SARS-CoV-2 Infection and Vaccines in Solid Organ Transplant Recipients. Viruses 2021;13:1879. [PMID: 34578460 DOI: 10.3390/v13091879] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 An W, Wang Q, Kim T, Kang J. Clinical characteristics and outcome of coronavirus disease 2019 infection in patients with solid organ transplants: A systematic review and meta-analysis. Journal of Infection and Public Health 2022. [DOI: 10.1016/j.jiph.2022.02.002] [Reference Citation Analysis]
3 Roest S, Brugts JJ, van Kampen JJA, von der Thüsen JH, Constantinescu AA, Caliskan K, Hirsch A, Manintveld OC. COVID-19-related myocarditis post-heart transplantation. Int J Infect Dis 2021;107:34-6. [PMID: 33862215 DOI: 10.1016/j.ijid.2021.04.013] [Reference Citation Analysis]
4 Bartelt L, van Duin D. An Overview of COVID-19 in solid organ transplantation. Clinical Microbiology and Infection 2022. [DOI: 10.1016/j.cmi.2022.02.005] [Reference Citation Analysis]
5 Chandar R, Swaminathan VV, Meena S, Varla H, Uppuluri R, Raj R. The impact of COVID-19 in children post hematopoietic stem cell transplantation: Experience from a pediatric transplant unit in India. Pediatric Hematology Oncology Journal 2021. [DOI: 10.1016/j.phoj.2021.12.003] [Reference Citation Analysis]
6 Migo W, Boskovic M, Likic R. The development of biologics to target SARS-CoV2: Treatment potential of antibodies in patient groups with poor immune response. Curr Res Pharmacol Drug Discov 2021;2:100064. [PMID: 34870159 DOI: 10.1016/j.crphar.2021.100064] [Reference Citation Analysis]
7 Sen R, Sengupta D, Mukherjee A. Mechanical dependency of the SARS-CoV-2 virus and the renin-angiotensin-aldosterone (RAAS) axis: a possible new threat. Environ Sci Pollut Res Int 2021. [PMID: 34859345 DOI: 10.1007/s11356-021-16356-2] [Reference Citation Analysis]
8 Dolan SA, Mulcahy Levy J, Moss A, Pearce K, Butler M, Jung S, Dominguez SR, Mwangi E, Maloney K, Rao S. SARS-CoV-2 persistence in immunocompromised children. Pediatr Blood Cancer 2021;68:e29277. [PMID: 34453477 DOI: 10.1002/pbc.29277] [Reference Citation Analysis]
9 Lafarge A, Mabrouki A, Yvin E, Bredin S, Binois Y, Clere-Jehl R, Azoulay E. Coronavirus disease 2019 in immunocompromised patients: a comprehensive review of coronavirus disease 2019 in hematopoietic stem cell recipients. Curr Opin Crit Care 2022;28:83-9. [PMID: 34813523 DOI: 10.1097/MCC.0000000000000907] [Reference Citation Analysis]
10 Shah SB. COVID-19 and Progesterone: Part 2. Unraveling High Severity, Immunity Patterns, Immunity grading, Progesterone and its potential clinical use. Endocr Metab Sci 2021;:100110. [PMID: 34396354 DOI: 10.1016/j.endmts.2021.100110] [Reference Citation Analysis]
11 Leung C, de Paiva KM. Is pregnancy a risk factor for in-hospital mortality in reproductive-aged women with SARS-CoV-2 infection? A nationwide retrospective observational cohort study. Int J Gynaecol Obstet 2021. [PMID: 34888871 DOI: 10.1002/ijgo.14066] [Reference Citation Analysis]
12 Larijani B, Foroughi-Heravani N, Abedi M, Tayanloo-Beik A, Rezaei-Tavirani M, Adibi H, Arjmand B. Recent Advances of COVID-19 Modeling Based on Regenerative Medicine. Front Cell Dev Biol 2021;9:683619. [PMID: 34760882 DOI: 10.3389/fcell.2021.683619] [Reference Citation Analysis]
13 Nomoto H, Suzuki S, Asai Y, Hayakawa K, Gatanaga H, Terada M, Suzuki K, Ohtsu H, Toyoda A, Ohmagari N. Clinical characteristics and prognosis of immunosuppressed inpatients with COVID-19 in Japan. J Infect Chemother 2021:S1341-321X(21)00294-4. [PMID: 34776348 DOI: 10.1016/j.jiac.2021.10.021] [Reference Citation Analysis]
14 Hernandez-Garcia E, Chrysikou E, Kalea AZ. The Interplay between Housing Environmental Attributes and Design Exposures and Psychoneuroimmunology Profile-An Exploratory Review and Analysis Paper in the Cancer Survivors' Mental Health Morbidity Context. Int J Environ Res Public Health 2021;18:10891. [PMID: 34682637 DOI: 10.3390/ijerph182010891] [Reference Citation Analysis]
15 Hertanto DM, Wiratama BS, Sutanto H, Wungu CDK. Immunomodulation as a Potent COVID-19 Pharmacotherapy: Past, Present and Future. J Inflamm Res 2021;14:3419-28. [PMID: 34321903 DOI: 10.2147/JIR.S322831] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Jacobson C, Miller N, Mulholland R, Baker L, Glazer D, Betts E, Brown L, Elders V, Carr R, Ogundiran O, Hudson LD. Psychological distress and resilience in a multicentre sample of adolescents and young adults with cancer during the COVID-19 pandemic. Clin Child Psychol Psychiatry 2021;:13591045211056923. [PMID: 34865537 DOI: 10.1177/13591045211056923] [Reference Citation Analysis]
17 Krajewski J, Chen J, Motiani J, Baer A, Appel B, Zakrzewski J, Hankewycz M, Durning N, Gillio A. Hematopoietic stem cell transplant in two pediatric patients testing positive for SARS-CoV-2: A case report. Pediatr Transplant 2021;:e14179. [PMID: 34708505 DOI: 10.1111/petr.14179] [Reference Citation Analysis]
18 Haeusler GM, Ammann RA, Carlesse F, Groll AH, Averbuch D, Castagnola E, Agyeman PKA, Phillips B, Gilli F, Solopova G, Attarbaschi A, Wegehaupt O, Speckmann C, Sung L, Lehrnbecher T. SARS-CoV-2 in children with cancer or after haematopoietic stem cell transplant: An analysis of 131 patients. Eur J Cancer 2021;159:78-86. [PMID: 34736044 DOI: 10.1016/j.ejca.2021.09.027] [Reference Citation Analysis]
19 Wang L, Li G, Yuan C, Yang Y, Ling G, Zheng J, Zhou Y, Zhang T, Lin W, Lin Z. Progress in the Diagnosis and Treatment of COVID-19 in Children: A Review. Int J Gen Med 2021;14:8097-108. [PMID: 34795516 DOI: 10.2147/IJGM.S335888] [Reference Citation Analysis]
20 Scharringa S, Hoffman T, van Kessel DA, Rijkers GT. Vaccination and their importance for lung transplant recipients in a COVID-19 world. Expert Rev Clin Pharmacol 2021;:1-13. [PMID: 34328054 DOI: 10.1080/17512433.2021.1961577] [Reference Citation Analysis]
21 Tang K, Wu X, Luo Y, Wei Z, Feng L, Wu L. Meta-analysis of Immunologic response after COVID-19 mRNA vaccination in solid organ transplant recipients. Journal of Infection 2022. [DOI: 10.1016/j.jinf.2022.02.016] [Reference Citation Analysis]
22 Raj R, Uppuluri R, Parambil B, Dhariwal N, Totadri S, Mathew LG, Radhakrishnan V, Charan A, Yadav SP, Mahajan A, Mudaliar S, Sharma R, Manglani M, Kharya G, Verma N, Arora R, Ghara N, Ks R, Radhakrishnan N, Iyer N, Mehta P, Singh A, Patel S, John J, Bhat S, Badiger S, Siddaiahgari S, Kakkar S, Scott J, Jayaraman D, Srinivasan A, Krishnan Y, Sonamani N, Misra R, Bafna V, Seth R, Kutty PK, Kanakia S, Rao V, Prakash A, Bharadwaj V, Chinnasamy G. Outcomes of COVID-19 in children with cancer – Report from the Indian Pediatric Oncology Group (InPOG) COVID-19 registry in India. Pediatric Hematology Oncology Journal 2022. [DOI: 10.1016/j.phoj.2022.03.002] [Reference Citation Analysis]
23 Monfared A, Akhondzadeh L, Mousazadeh M, Jafari A, Khosravi M, Lebadi M, Aghajanzadeh P, Haghdar-Saheli Y, Movassaghi A, Ramezanzadeh E, Shobeirian F, Kazemnezhad E, Esmaeili S. COVID-19 in renal transplant recipients and general population: a comparative study of clinical, laboratory, and radiological features, severity, and outcome. Virol J 2021;18:243. [PMID: 34876176 DOI: 10.1186/s12985-021-01713-x] [Reference Citation Analysis]
24 Alberca RW, Alberca GGF, Netto LC, Orfali RL, Gozzi-silva SC, da Silva Duarte AJ, Aoki V, Sato MN, Benard G. COVID-19 Severity and Mortality in Solid Organ Transplantation: Differences between Liver, Heart, and Kidney Recipients. Transplantology 2021;2:296-303. [DOI: 10.3390/transplantology2030030] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Arabpour E, Khoshdel S, Tabatabaie N, Akhgarzad A, Zangiabadian M, Nasiri MJ. Stem Cells Therapy for COVID-19: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021;8:737590. [PMID: 34912818 DOI: 10.3389/fmed.2021.737590] [Reference Citation Analysis]
26 Milota T, Sobotkova M, Smetanova J, Bloomfield M, Vydlakova J, Chovancova Z, Litzman J, Hakl R, Novak J, Malkusova I, Hanzlikova J, Jilek D, Hutyrova B, Novak V, Krcmova I, Sediva A, Kralickova P. Risk Factors for Severe COVID-19 and Hospital Admission in Patients With Inborn Errors of Immunity - Results From a Multicenter Nationwide Study. Front Immunol 2022;13:835770. [DOI: 10.3389/fimmu.2022.835770] [Reference Citation Analysis]
27 Fernández-Ruiz M, Aguado JM. Severe acute respiratory syndrome coronavirus 2 infection in the stem cell transplant recipient - clinical spectrum and outcome. Curr Opin Infect Dis 2021;34:654-62. [PMID: 34751184 DOI: 10.1097/QCO.0000000000000790] [Reference Citation Analysis]
28 Ganjei Z, Faraji Dana H, Ebrahimi-Dehkordi S, Alidoust F, Bahmani K. Methotrexate as a safe immunosuppressive agent during the COVID-19 pandemic. Int Immunopharmacol 2021;101:108324. [PMID: 34731780 DOI: 10.1016/j.intimp.2021.108324] [Reference Citation Analysis]
29 Ng A. Graft injury and re-transplantation in liver transplant patients with COVID-19. Journal of Liver Transplantation 2021;1:100008. [DOI: 10.1016/j.liver.2021.100008] [Reference Citation Analysis]
30 Grupper A, Katchman H. SARS-CoV-2 Vaccines: Safety and Immunogenicity in Solid Organ Transplant Recipients and Strategies for Improving Vaccine Responses. Curr Transpl Rep. [DOI: 10.1007/s40472-022-00359-0] [Reference Citation Analysis]
31 Sharma A, Bhatt NS, Hijano DR. Clinical experience of coronavirus disease 2019 in hematopoietic cell transplant and chimeric antigen receptor T-cell recipients. Curr Opin Hematol 2021;28:394-400. [PMID: 34456224 DOI: 10.1097/MOH.0000000000000683] [Reference Citation Analysis]
32 Patrucco F, Airoldi C, Falaschi Z, Bellan M, Castello LM, Filippone F, Matranga S, Masellis S, Smeriglia A, Solidoro P, Balbo PE, Gavelli F. Mycotic infection prevalence among patients undergoing bronchoalveolar lavage with search of SARS-CoV-2 after two negative nasopharyngeal swabs. J Breath Res 2021;15. [PMID: 34464944 DOI: 10.1088/1752-7163/ac2290] [Reference Citation Analysis]
33 Hertanto DM, Sutanto H, Wiratama BS, Wungu CDK. Modulating the host immune response to fight against COVID-19: Where are we in 2021? Virulence 2021;12:1732-6. [PMID: 34224330 DOI: 10.1080/21505594.2021.1943275] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
34 Sinha R, Marlais M, Sarkar S, Obukhova V, Lucchetti L, Vasudevan A, Chacon Jaimes DC, Weaver DJ Jr, Stańczyk M, Lopez-Gonzalez M, Schaefer F, Tullus K. Impact of COVID-19 pandemic on use of rituximab among children with difficult nephrotic syndrome. Pediatr Res 2021. [PMID: 34548632 DOI: 10.1038/s41390-021-01744-8] [Reference Citation Analysis]
35 Sarabia De Ardanaz L, Andreu-Ubero JM, Navidad-Fuentes M, Ferrer-González MÁ, Ruíz Del Valle V, Salcedo-Bellido I, Barrios-Rodríguez R, Cáliz-Cáliz R, Requena P. Tocilizumab in COVID-19: Factors Associated With Mortality Before and After Treatment. Front Pharmacol 2021;12:620187. [PMID: 34276355 DOI: 10.3389/fphar.2021.620187] [Reference Citation Analysis]